|
|
|
EuroSciCon, Cineworld: The O2 Peninsula Square London London SE10 0DX United Kingdom
Monday 2nd June 2014
This event will highlight and discuss recent advances in strategies for controlling stem cell fate and reprogramming. Progress towards therapeutic applications, and new insights into the molecular basis of pluripotency, differentiation, and transdifferentiation will be discussed in an informal setting with plenty of opportunity for networking. This event has CPD accreditation. This event is part of The 2014 Tissue Engineering Congress. Who Should Attend Biotech and Pharma Industry: CEOs, Chief Scientists, Group Heads, Senior and Junior Scientists, Research Managers Academic and Research Institutes: Group and Lab Heads, Postdoctoral Scientists and Research Students
Meeting Chair: Dr Christopher Ward, Senior Lecturer in Stem Cell Biology, The University ofManchester, UK
The deadline for abstract submissions for oral presentation is March 10th 2014.Abstracts for poster presentation only can be submitted up to two weeks before the event. You can download the instructions for authors at:www.euroscicon.com/AbstractsForOralAndPosterPresentation.pdf
Keywords: iPSC, hepatocyte, liver, CYP p450, translation, supply chain, delivery, GMP, manufacturing,drug, pluripotent stem cell, hepatocyte, pancreas, liver; beta-cell, Stable Karyoytpe, High-throughput efficiency, Embryonic Stem cells, Induced pluripotency, Nanog, neural stem cell, glioblastoma, DNA methylation, reprogramming, iPS cells, reprogramming, Pluripotentcy, STEMCCA, ESGRO 2i, Pluripotency; reprogramming; chromatin signatures; DNA replication timing; histone acetyltransferase p30, hESC, Drug Metabolism, Hepatocyte, Liver, reprogramming, characterisation, Parkinsons, culture, Chemical Reprogramming, Amniotic Fluid Stem Cells, Induced Pluripotent Stem Cells, Pluripotency Regenerative Medicine, cardiomyocytes, heart disease, human pluripotent stem cells, human neural stem cells, Wnt signalling
|
|
|
|
|
|
Organized by:
|
|
Euroscicon |
|
Invited Speakers:
|
|
Talks include
Progressing human pluripotent stem cell technologies for drug discovery and regenerative medicine by genome engineering Dr Peter Sartipy, Cellectis AB, Göteborg, Sweden
Chemical Reprogramming of Human Amniotic FLuid Stem Cells to Pluripotency Dr Pascale V Guillot, Senior Lecturer, University College London, UK
Cell Sex Matters. It Could Affect Findings Dr Elizabeth Pollitzer, Portia, London, UK
Disease modelling in a dish: use of cardiovascular derivatives of human pluripotent stem cells Dr Gabor Foldes, Imperial College London, UK
Regulation of human neural stem cell differentiation by noncanonical Wnt signaling Dr Robert Kypta, Group Leader, Center for Cooperative Research in Biosciences (CIC bioGUNE) and Imperial College London, UK
Heterogeneity in pluripotent stem cell populations Dr Kirsten Mcewen, MRC Clinical Sciences Centre, UK
Additional confirmed speakers Dr Christopher Ward, Senior Lecturer in Stem Cell Biology, The University of Manchester, UK Speaker to be confirmed, MTS Cryostores, UK
|
|
|
|
|
|
Deadline for Abstracts:
|
|
The deadline for abstract submissions for oral presentation is March 10th 2014.
|
|
|
|
|
|
Registration:
|
|
Registration Website:www.regonline.co.uk/Regen2014
|
|
E-mail:
|
|
enquiries@euroscicon.com
|
|
|
|
|
|
|
|